Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Cervical Cancer

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 66 articles: HTML format Text format

Single Articles

May 2012
1. BARKEN SS , Rebolj M, Andersen ES, Lynge E, et al
   Frequency of cervical intraepithelial neoplasia treatment in a well-screened population.
   Int J Cancer. 2012;130:2438-44.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   April 2012
2. HALEC G , Schmitt M, Dondog B, Sharkhuu E, et al
   Biological activity of probable/possible high-risk human papillomavirus types in cervical cancer.
   Int J Cancer. 2012 Apr 19. doi: 10.1002/ijc.27605.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2012
3. GOK M , van Kemenade FJ, Heideman DA, Berkhof J, et al
   Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program.
   Int J Cancer. 2012;130:1128-35.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   February 2012
4. AZERKAN F , Sparen P, Sandin S, Tillgren P, et al
   Cervical screening participation and risk among Swedish-born and immigrant women in Sweden.
   Int J Cancer. 2012;130:937-47.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. ROOSSINK F , Wieringa HW, Noordhuis MG, Ten Hoor KA, et al
   The role of ATM and 53BP1 as predictive markers in cervical cancer.
   Int J Cancer. 2012 Feb 10. doi: 10.1002/ijc.27488.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2012
6. REUSCHENBACH M , Seiz M, von Knebel Doeberitz C, Vinokurova S, et al
   Evaluation of cervical cone biopsies for coexpression of p16INK4a and Ki-67 in epithelial cells.
   Int J Cancer. 2012;130:388-94.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
7. HAUPT RM , Wheeler CM, Brown DR, Garland SM, et al
   Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infection.
   Int J Cancer. 2011;129:2632-42.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
8. KHODAKARAMI N , Clifford GM, Yavari P, Farzaneh F, et al
   Human papillomavirus infection in women with and without cervical cancer in Tehran, Iran.
   Int J Cancer. 2011 Oct 31. doi: 10.1002/ijc.26488.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. JAAKKOLA S , Pukkala E, Lyytinen HK, Ylikorkala O, et al
   Postmenopausal estradiol-progestagen therapy and risk for uterine cervical cancer.
   Int J Cancer. 2011 Oct 25. doi: 10.1002/ijc.27321.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
10. CHEN RJ , Chen SU, Chou CH, Lin MC, et al
    Lysophosphatidic acid receptor 2/3-mediated IL-8-dependent angiogenesis in cervical cancer cells.
    Int J Cancer. 2011 Sep 30. doi: 10.1002/ijc.26476.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. VANNI T , Mendes Luz P, Grinsztejn B, Veloso VG, et al
    Cervical cancer screening among HIV-infected women: An economic evaluation in a middle-income country.
    Int J Cancer. 2011 Sep 30. doi: 10.1002/ijc.26472.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
12. ZHANG X , Wang C, Wang L, Du L, et al
    Detection of circulating Bmi-1 mRNA in plasma and its potential diagnostic and prognostic value for uterine cervical cancer.
    Int J Cancer. 2011 Aug 19. doi: 10.1002/ijc.26360.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. CHANG YJ , Chen HC, Lee BH, You SL, et al
    Unique variants of human papillomavirus genotypes 52 and 58 and risk of cervical neoplasia.
    Int J Cancer. 2011;129:965-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. DECRAUSAZ L , Domingos-Pereira S, Duc M, Bobst M, et al
    Parenteral is more efficient than mucosal immunization to induce regression of human papillomavirus-associated genital tumors.
    Int J Cancer. 2011;129:762-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. VANNI T , Legood R, Franco EL, Villa LL, et al
    Economic evaluation of strategies for managing women with equivocal cytological results in Brazil.
    Int J Cancer. 2011;129:671-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
16. CAMPOS NG , Kim JJ, Castle PE, Ortendahl JD, et al
    Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa.
    Int J Cancer. 2011 Jun 29. doi: 10.1002/ijc.26269.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. PLUMMER M , Peto J, Franceschi S
    Time since first sexual intercourse and the risk of cervical cancer.
    Int J Cancer. 2011 Jun 23. doi: 10.1002/ijc.26250.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
18. HERNANDEZ-PLATA E , Ortiz CS, Marquina-Castillo B, Medina-Martinez I, et al
    Over expression of Na(V) 1.6 channels is associated with the invasion capacity of human cervical cancer.
    Int J Cancer. 2011 May 31. doi: 10.1002/ijc.26210.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. JUNG HS , Erkin OC, Kwon MJ, Kim SH, et al
    Human papillomavirus E6/E7 siRNA potentiates the therapeutic effect of cisplatin in cervical cancer cell lines In vitro and In vivo.
    Int J Cancer. 2011 May 31. doi: 10.1002/ijc.26197.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. DECRAUSAZ L , Goncalves AR, Domingos-Pereira S, Pythoud C, et al
    A novel mucosal orthotopic murine model of human papillomavirus-associated genital cancers.
    Int J Cancer. 2011;128:2105-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. HAMMOUDA D , Clifford GM, Pallardy S, Ayyach G, et al
    Human papillomavirus infection in a population-based sample of women in Algiers, Algeria.
    Int J Cancer. 2011;128:2224-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
22. AULT KA , Joura EA, Kjaer SK, Iversen OE, et al
    Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine.
    Int J Cancer. 2011;128:1344-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. STOLER MH , Vichnin MD, Ferenczy A, Ferris DG, et al
    The accuracy of colposcopic biopsy: analyses from the placebo arm of the Gardasil clinical trials.
    Int J Cancer. 2011;128:1354-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. RIJKAART DC , Berkhof J, van Kemenade FJ, Coupe VM, et al
    Evaluation of 14 triage strategies for HPV DNA positive women in population-based cervical screening.
    Int J Cancer. 2011 Mar 11. doi: 10.1002/ijc.26056.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. SHI JF , Canfell K, Lew JB, Qiao YL, et al
    The burden of cervical cancer in China: Synthesis of the evidence.
    Int J Cancer. 2011 Mar 8. doi: 10.1002/ijc.26042.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. CASTRO FA , Ivansson EL, Schmitt M, Juko-Pecirep I, et al
    Contribution of TMC6 and 8 (EVER1 and2) variants to cervical cancer susceptibility.
    Int J Cancer. 2011 Mar 8. doi: 10.1002/ijc.26016.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. CHEN HC , You SL, Hsieh CY, Schiffman M, et al
    Prevalence of genotype-specific human papillomavirus infection and cervical neoplasia in Taiwan: a community-based survey of 10,602 women.
    Int J Cancer. 2011;128:1192-203.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
28. WANG H , Song X, Zhang H, Zhang J, et al
    Potentiation of tumor radiotherapy by a radiation-inducible oncolytic and oncoapoptotic adenovirus in cervical cancer xenografts.
    Int J Cancer. 2011 Feb 23. doi: 10.1002/ijc.26013.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. DAUD II , Scott ME, Ma Y, Shiboski S, et al
    Association between toll-like receptor expression and human papillomavirus type 16 persistence.
    Int J Cancer. 2011;128:879-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. GRAVITT PE , Belinson JL, Salmeron J, Shah KV, et al
    Looking ahead: A case for HPV testing of self-sampled vaginal specimens as a cervical cancer screening strategy.
    Int J Cancer. 2011 Feb 3. doi: 10.1002/ijc.25974.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. SAHASRABUDDHE VV , Bhosale RA, Kavatkar AN, Nagwanshi CA, et al
    Comparison of visual inspection with acetic acid (VIA) and cervical cytology to detect high grade cervical neoplasia among HIV-infected women in India.
    Int J Cancer. 2011 Feb 3. doi: 10.1002/ijc.25971.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. CHAO A , Jao MS, Huang CC, Huang HJ, et al
    Human papillomavirus genotype in cervical intraepithelial neoplasia grades 2 and 3 of Taiwanese women.
    Int J Cancer. 2011;128:653-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
33. LOPEZ TV , Lappin TR, Maxwell P, Shi Z, et al
    Autocrine/paracrine erythropoietin signalling promotes JAK/STAT-dependent proliferation of human cervical cancer cells.
    Int J Cancer. 2011 Jan 20. doi: 10.1002/ijc.25935.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. WANG PH , Ko JL, Yang SF, Lin LY, et al
    Implication of human nonmetastatic clone 23 Type 1 and its downstream gene lipocalin 2 in metastasis and patient's survival of cancer of uterine cervix.
    Int J Cancer. 2011 Jan 20. doi: 10.1002/ijc.25936.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. FRANCESCHI S , Denny L, Irwin KL, Jeronimo J, et al
    Eurogin 2010 roadmap on cervical cancer prevention.
    Int J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
36. CLIFFORD GM , Howell-Jones R, Franceschi S
    Judging the carcinogenicity of human papillomavirus types by single:multiple infection ratio in cervical cancer.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
37. WANG X , Meyers C, Guo M, Zheng ZM, et al
    Up-regulation of p18Ink4c expression by oncogenic HPV E6 via p53-miR-34a pathway.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
38. SIGHOKO D , Bah E, Haukka J, McCormack VA, et al
    Population-based breast (female) and cervix cancer rates in the Gambia: evidence of ethnicity-related variations.
    Int J Cancer. 2010;127:2248-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. VACCARELLA S , Clifford GM, Howell-Jones R, Snijders PJ, et al
    Response to: Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
40. SILFVERDAL L , Kemetli L, Sparen P, Andrae B, et al
    Risk of invasive cervical cancer in relation to clinical investigation and treatment after abnormal cytology: A population-based case-control study.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. SONG YJ , Kim JY, Lee SK, Lim HS, et al
    Persistent human papillomavirus DNA is associated with local recurrence after radiotherapy of uterine cervical cancer.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. HEYMANS J , Benoy IH, Poppe W, Depuydt CE, et al
    Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
43. TAYLOR S , Wang C, Wright TC, Denny L, et al
    A comparison of HPV testing of clinician-collected and self-collected samples during follow-up after screen-and-treat.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. DAHLSTROM LA , Ylitalo N, Sundstrom K, Palmgren J, et al
    Prospective study of human papillomavirus and risk of cervical adenocarcinoma.
    Int J Cancer. 2010;127:1923-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. MONSONEGO J , Hudgens MG, Zerat L, Zerat JC, et al
    Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid based cytology in primary cervical cancer screening (The FASE study).
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
46. GONZALEZ CA , Travier N, Lujan L, Castellsague X, et al
    Dietary factors and in-situ and invasive cervical cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. ANTTILA A , Pokhrel A, Kotaniemi-Talonen L, Hakama M, et al
    Cervical cancer patterns with automation-assisted and conventional cytological screening: A randomized study.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. BELINSON JL , Hu S, Niyazi M, Pretorius RG, et al
    Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: Implications for vaginal self-collection.
    Int J Cancer. 2010;127:1151-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. BACHRAN D , Schneider S, Bachran C, Urban R, et al
    Epidermal growth factor receptor expression affects the efficacy of the combined application of saponin and a targeted toxin on human cervical carcinoma cells.
    Int J Cancer. 2010;127:1453-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
50. HO CM , Lee BH, Chang SF, Chien TY, et al
    Type-specific human papillomavirus oncogene messenger RNA levels correlate with the severity of cervical neoplasia.
    Int J Cancer. 2010;127:622-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
51. VIRTANEN A , Anttila A, Luostarinen T, Nieminen P, et al
    Self-sampling vs. Reminder letter: Effects on cervical cancer screening attendance and coverage in Finland.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. TERMINI L , Maciag PC, Soares FA, Nonogaki S, et al
    Analysis of human kallikrein 7 expression as a potential biomarker in cervical neoplasia.
    Int J Cancer. 2010;127:485-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. LI Y , Xing D, Chen Q, Chen WR, et al
    Enhancement of chemotherapeutic agent-induced apoptosis by inhibition of NF-kappaB using ursolic acid.
    Int J Cancer. 2010;127:462-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. DE KOK IM , van der Aa MA, van Ballegooijen M, Siesling S, et al
    Trends in cervical cancer in the Netherlands until 2007: Has the bottom been reached?
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
55. ARBYN M , Antoine J, Magi M, Smailyte G, et al
    Trends in cervical cancer incidence and mortality in the Baltic countries, Bulgaria and Romania.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
56. POWELL N , Hibbitts S, Boyde A, Newcombe R, et al
    The risk of cervical cancer associated with specific types of Human Papillomavirus: A case control study in a UK population.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. DECRAUSAZ L , Revaz V, Bobst M, Corthesy B, et al
    Induction of human papillomavirus oncogene-specific CD8 T-cell effector responses in the genital mucosa of vaccinated mice.
    Int J Cancer. 2010;126:2469-78.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. YASMEEN A , Zhang L, Al Moustafa AE
    Does the vesicular stomatitis virus really have a selective oncolytic effect in human cancer?
    Int J Cancer. 2010;126:2509-10.
    PubMed     Text format     Related articles   
    
    
    
    April 2010
59. LI N , Franceschi S, Howell-Jones R, Snijders PJ, et al
    Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. KIM YT , Lee JM, Hur SY, Cho CH, et al
    Clearance of human papillomavirus infection after successful conization in patients with cervical intraepithelial neoplasia.
    Int J Cancer. 2010;126:1903-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. HEUSINKVELD M , Welters MJ, van Poelgeest MI, van der Hulst JM, et al
    The detection of circulating Human Papillomavirus (HPV)-specific T cells is associated with improved survival of patients with deeply infiltrating tumors.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
62. OHLSCHLAGER P , Spies E, Alvarez G, Quetting M, et al
    The combination of TLR-9 adjuvantation and electroporation mediated delivery enhances in vivo anti-tumor responses after vaccination with HPV-16 E7 encoding DNA.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
63. BERKHOF J , Coupe VM, Bogaards JA, van Kemenade FJ, et al
    The health and economic effects of HPV DNA screening in the netherlands.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. MOSCICKI AB , Widdice L, Ma Y, Farhat S, et al
    Comparison of natural histories of human papillomavirus (HPV) detected by clinician- and self- sampling.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. DARVAS K , Rosenberger S, Brenner D, Fritsch C, et al
    Histone deacetylase inhibitor-induced sensitization to TNFalpha/TRAIL-mediated apoptosis in cervical carcinoma cells is dependent on HPV oncogene expression.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2009
66. RIJKAART DC , Berkhof J, van Kemenade FJ, Rozendaal L, et al
    Comparison of HPV and cytology triage algorithms for women with borderline or mild dyskaryosis in population-based cervical screening (vusa-screen study).
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: